Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Breast Cancer Clinical Advisory Board
    • Cancer Business Advisory Board
  • Technologies
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Cancer Vaccines
      • Introduction
      • Markets
      • Science
      • Collaborators
      • Breast Cancer Clinical Advisory Board
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Publications
    • YouTube Channel
  • Contact Us

Annual Reports

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Fact Sheet
    • Contact IR
    • RSS News Feed
  • Financial Reports

  • Annual Reports
  • Quarterly Reports
Filter Filings:
Date Form Description Docs XBRL Pages
12/07/16 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-4.2
EX-10.19
EX-10.20
EX-10.21
EX-21
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-99.1
EX-99.2
EX-99.1
HTML PDF 138
12/23/15 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-21
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 97
01/29/15 10-K/A Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF 15
01/29/15 10-K Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-21
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 101
04/16/14 10-K/A Annual report pursuant to section 13 and 15(d)
Related Documents
EX-31
EX-31
EX-32
EX-32
HTML PDF 41
01/17/14 10-K/A Annual report pursuant to section 13 and 15(d) HTML PDF XBRL Viewer XLS XBRL Files 6
01/16/14 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-3
EX-21
EX-23
EX-31
EX-31
EX-32
EX-32
HTML PDF 111
08/27/13 ARS Annual report to security holders HTML PDF 108
01/29/13 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-3
EX-10
EX-10
EX-10
EX-10
EX-10
EX-10
EX-10
EX-23
EX-31
EX-31
EX-32
EX-32
HTML PDF XBRL Viewer XLS XBRL Files 244
01/30/12 10-K Annual report pursuant to section 13 and 15(d)
Related Documents
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
HTML PDF XBRL Viewer XLS XBRL Files 94
RSS
  • << Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next >>

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

May 19, 2025

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

Read More...
May 12, 2025

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read More...
Apr 30, 2025

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

Read More...
Copyrights © 2025 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap